HN2002000312A - BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS - Google Patents
BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONSInfo
- Publication number
- HN2002000312A HN2002000312A HN2002000312A HN2002000312A HN2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A
- Authority
- HN
- Honduras
- Prior art keywords
- formulations
- antagonist activity
- linear compounds
- basic linear
- compounds
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a compuestos antagonistas de taquiquinas en general, y en modo general, y en modo particular de la neuroquina A, y a su empleo en formulaciones farmacéuticas. Las Taquiquininas constituyen una familia que incluye, como mínimo, tres péptidos que son conocidos como sustancia P, Neuroquinina A (NKA) Y Neuroquinina B (NKB). En la presente se describen los compuestos de la fórmula (I) que resultan de utilidad como antagonistas de taquininas en general, y en particular de la neuroquinina A; y las formulaciones que comprenden los compuestos de la fórmula (I)The present invention relates to antagonist compounds of tachykin in general, and in general, and in particular of neurokine A, and their use in pharmaceutical formulations. Tachykinins are a family that includes at least three peptides that are known as substance P, Neurokinin A (NKA) and Neurokinin B (NKB). The compounds of formula (I) that are useful as antagonists of takinins in general, and of neurokinin A in particular, are described herein; and formulations comprising the compounds of formula (I)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFI20010203 ITFI20010203A1 (en) | 2001-10-29 | 2001-10-29 | LINEAR COMPOUNDS WITH BASIC CHARACTERISTICS WITH ACTIVITY NK-2 ANTAGONIST, THEIR SYNTHESIS PROCESSES AND FORMULATIONS THAT CONTAIN THEM |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2002000312A true HN2002000312A (en) | 2005-12-20 |
Family
ID=27620690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2002000312A HN2002000312A (en) | 2001-10-29 | 2002-10-28 | BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS |
Country Status (2)
Country | Link |
---|---|
HN (1) | HN2002000312A (en) |
IT (1) | ITFI20010203A1 (en) |
-
2001
- 2001-10-29 IT ITFI20010203 patent/ITFI20010203A1/en unknown
-
2002
- 2002-10-28 HN HN2002000312A patent/HN2002000312A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ITFI20010203A1 (en) | 2003-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8548401A1 (en) | ANTIBACTERIAL AGENTS | |
PL420160A1 (en) | Veterinary antiparasitic oral compositions, that include systemically acting active substances, methods and applications covering them | |
CY1109010T1 (en) | c-crystalline form of hydrochloride ivabradine, its preparation method and the pharmaceutical compositions containing it | |
CY1110262T1 (en) | Substituted Pepperidine Compounds for Use as H3 receptor antagonists | |
UY27729A1 (en) | QUINASE INHIBITORS. | |
UY28572A1 (en) | NEW COMPOUNDS | |
UY28906A1 (en) | PIRIMIDINE DERIVATIVES THAT ARE ANTAGONISTS OF THE VITRONECTINE RECEPTOR | |
ITMI20050328A1 (en) | PEPTIDOMIMETRIC COMPOUNDS AND PREPARATION OF BIOLOGICALLY ACTIVE DERIVATIVES | |
CY1108797T1 (en) | A-CRYSTAL FORM OF RANELIC STRONTIUM, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
EA200701065A1 (en) | INJECTABLE COMPOSITIONS CONTAINING NANODISPERS Olanzapine | |
GT200700096A (en) | PIRAZOLINE COMPOUNDS | |
CY1105847T1 (en) | LINEAR BASIC COMPOUNDS EXHIBITING NK-2 ANTAGONIST ACTIVITY AND PREPARATION THEREOF | |
NO20063393L (en) | Pharmaceutical preparations | |
PA8553701A1 (en) | ANTIDIABETIC AGENTS | |
CY1123382T1 (en) | ORAL AND INJECTABLE AND PREPARATION OF TETRACYCLINE COMPOUNDS | |
UY27851A1 (en) | DIFENILAZETIDINONAS REPLACED IN RING, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE. | |
UY28247A1 (en) | BENZOPIRAN COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF AFFECTIONS RELATED TO INFLAMMATION. | |
HN2002000312A (en) | BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS | |
BRPI0417205A (en) | pharmaceutical compositions | |
DE60322110D1 (en) | SUBSTITUTED 4- (4-PIPERIDIN-YL-PIPERAZIN-1-YL) -AZNTAGONISTS | |
DE602004014285D1 (en) | ABIOTIC HEPARIN ANTAGONISTS | |
DOP2002000386A (en) | ANTIBACTERIAL AGENTS | |
CY1108865T1 (en) | Substituted 2,5-diaminobutyl-1H-pyrroles | |
DE602005011314D1 (en) | 4-HYDROXYTAMOXIFENGEL FORMULATIONS | |
UY31541A1 (en) | 1 (2) H-TETRAZOL-5-IL-FENIL-OXAZOLIDINONA S AS ANTIBACTERIAL AGENTS |